One of our missions is to accelerate research. We make it a priority to both fund and track current research. You can support research as a donor and by encouraging family members to join the Data Collection Program.
We partnered with RARE-X, a collaborative platform for global data sharing and analysis, to accelerate treatments for rare disease.
Wake Forest Institute for Regenerative Medicine
Wake Forest Institute for Regenerative Medicine is currently researching gene therapy treatments for Dent disease. Fully funded by an anonymous Dent family, this research is now in its third year and is funded until completion.
Mayo Clinic is currently researching a possible chaperone drug therapy that may be able to help certain individuals with Dent disease. Funded by the Dent Disease Foundation, this potential treatment is in its first year.
Rare Kidney Stone Consortium
Drs. John C. Lieske, Mayo Clinic, Rochester, MN and Lada Beara Lasic, NYU Medical School, Department of Nephrology, NY manage the Rare Kidney Stone Consortium.